Home » Stocks » BLU

BELLUS Health Inc. (BLU)

Stock Price: $4.58 USD 0.19 (4.33%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 357.15M
Revenue (ttm) 11,765
Net Income (ttm) -24.91M
Shares Out 78.34M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $4.58
Previous Close $4.39
Change ($) 0.19
Change (%) 4.33%
Day's Open 4.33
Day's Range 4.28 - 4.62
Day's Volume 499,343
52-Week Range 2.01 - 12.03

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, April 16, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and Ju...

2 days ago - PRNewsWire

LOS ANGELES, April 16, 2021 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BELLUS" or "the...

2 days ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 13, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t...

5 days ago - Newsfile Corp

LOS ANGELES, April 13, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired B...

5 days ago - PRNewsWire

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

5 days ago - Business Wire

New York, New York--(Newsfile Corp. - April 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BEL...

6 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 12, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September...

6 days ago - Newsfile Corp

LOS ANGELES, April 12, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  May 17, 2021 deadline to file a lead plaintiff motion in the class action filed on beha...

6 days ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BELL...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 7, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging th...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 6, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BELL...

1 week ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - April 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("B...

1 week ago - Newsfile Corp

NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BELLUS Health Inc. ("BELLUS" or the "Company") (NASDAQ: BLU). Such investors are advised to contac...

1 week ago - PRNewsWire

LOS ANGELES, April 2, 2021 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BELLUS" or "the ...

2 weeks ago - PRNewsWire

BENSALEM, Pa., April 2, 2021 /PRNewswire/ -- Law Offices of Howard G.

2 weeks ago - PRNewsWire

NEW YORK, April 2, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class actio...

2 weeks ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September ...

2 weeks ago - Newsfile Corp

NEW YORK, March 31, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and Ju...

2 weeks ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 30, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BE...

2 weeks ago - Newsfile Corp

SAN DIEGO & LAVAL, Quebec--(BUSINESS WIRE)---- $BLU #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of BELLUS Health Inc. (NASDAQ: BLU) filed a class action complaint ag...

2 weeks ago - Business Wire

Los Angeles, California--(Newsfile Corp. - March 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("...

2 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BEL...

3 weeks ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 25, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("...

3 weeks ago - Newsfile Corp

SAN DIEGO--(BUSINESS WIRE)-- #BELLUScase--The suit alleges defendants issued false statements concerning BELLUS business and prospects, resulting in its stock trading at inflated prices.

3 weeks ago - Business Wire

New York, New York--(Newsfile Corp. - March 24, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t...

3 weeks ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $BLU #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the class action filed ...

3 weeks ago - Business Wire

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

3 weeks ago - Business Wire

New York, New York--(Newsfile Corp. - March 23, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of BELLUS Health Inc. .Shareholders...

3 weeks ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and July 5, 2020, in...

3 weeks ago - Business Wire

New York, New York--(Newsfile Corp. - March 23, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BE...

3 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 23, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased BELLUS Health Inc. ...

3 weeks ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $BLU #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of BELLUS Health Inc. (BLU) Investors

3 weeks ago - Business Wire

New York, New York--(Newsfile Corp. - March 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t...

3 weeks ago - Newsfile Corp

BENSALEM, Pa.--(BUSINESS WIRE)---- $BLU #CLASSACTION--Law Offices of Howard G. Smith reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the case filed on behalf o...

3 weeks ago - Business Wire

New York, New York--(Newsfile Corp. - March 22, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BE...

3 weeks ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against BELLUS Health Inc....

3 weeks ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $BLU #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of...

3 weeks ago - Business Wire

New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of BELLUS Health Inc. ("BELLUS" or the "Company") (NASDAQ: BLU). Such investors are a...

4 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 19, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities o...

4 weeks ago - Newsfile Corp

BENSALEM, Pa.--(BUSINESS WIRE)---- $BLU #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased BELLUS Health Inc. (“BELLUS...

4 weeks ago - Business Wire

Los Angeles, California--(Newsfile Corp. - March 19, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against BELLUS Health Inc....

4 weeks ago - Newsfile Corp

LOS ANGELES, March 18, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against BELLUS Health Inc. ("BELLUS" or "th...

1 month ago - PRNewsWire

LOS ANGELES--(BUSINESS WIRE)---- $BLU #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf ...

1 month ago - Business Wire

NEW YORK, March 18, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against BELLUS Health Inc. ("BELLUS" or ...

1 month ago - PRNewsWire

NEW YORK, March 17, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BELLUS Health Inc. ("BELLUS" or the "Company") (NASDAQ:  BLU).  Such investors are advised to con...

1 month ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 17, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t...

1 month ago - Newsfile Corp

NEW YORK, March 17, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of BELLUS Health...

1 month ago - PRNewsWire

LOS ANGELES--(BUSINESS WIRE)---- $BLU #investors--The Law Offices of Frank R. Cruz Announces Investigation of BELLUS Health Inc. (BLU) on Behalf of Investors

1 month ago - Business Wire

Los Angeles, California--(Newsfile Corp. - March 17, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against BELLUS Health Inc....

1 month ago - Newsfile Corp

BENSALEM, Pa.--(BUSINESS WIRE)---- $BLU #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of BELLUS Health Inc. (“BELLUS” or the “Company”) (NASDAQ: BLU) investors concer...

1 month ago - Business Wire

About BLU

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

Industry
Biotechnology
Founded
1993
CEO
Roberto Bellini
Employees
32
Stock Exchange
NASDAQ
Ticker Symbol
BLU
Full Company Profile

Financial Performance

In 2020, BELLUS Health's revenue was 15,000, a decrease of -44.44% compared to the previous year's 27,000. Losses were -31.76 million, 22.1% more than in 2019.

Financial numbers in millions CAD.
Financial Statements